ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2023

Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis.

Eusondia Arnett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.